Literature DB >> 23904210

Inactivating mutation in histone deacetylase 3 stabilizes its active conformation.

Mehrnoosh Arrar1, Cesar Augusto F de Oliveira, J Andrew McCammon.   

Abstract

Histone deacetylases (HDACs), together with histone acetyltransferases (HATs), regulate gene expression by modulating the acetylation level of chromatin. HDAC3 is implicated in many important cellular processes, particularly in cancer cell proliferation and metastasis, making inhibition of HDAC3 a promising epigenetic treatment for certain cancers. HDAC3 is activated upon complex formation with both inositol tetraphosphate (IP4) and the deacetylase-activating domain (DAD) of multi-protein nuclear receptor corepressor complexes. In previous studies, we have shown that binding of DAD and IP4 to HDAC3 significantly restricts its conformational space towards its stable ternary complex conformation, and suggest this to be the active conformation. Here, we report a single mutation of HDAC3 that is capable of mimicking the stabilizing effects of DAD and IP4, without the presence of either. This mutation, however, results in a total loss of deacetylase activity, prompting a closer evaluation of our understanding of the activation of HDAC3.
© 2013 The Protein Society.

Entities:  

Keywords:  HDAC3; R265P; allostery; conformational selection; molecular recognition

Mesh:

Substances:

Year:  2013        PMID: 23904210      PMCID: PMC3795489          DOI: 10.1002/pro.2317

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  21 in total

1.  Development of histone deacetylase inhibitors as therapeutics for neurological disease.

Authors:  Joel M Gottesfeld; Massimo Pandolfo
Journal:  Future Neurol       Date:  2009-11-01

Review 2.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer.

Authors:  Saverio Minucci; Pier Giuseppe Pelicci
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

Review 3.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

4.  Cloning and characterization of human histone deacetylase 8.

Authors:  I Van den Wyngaert; W de Vries; A Kremer; J Neefs; P Verhasselt; W H Luyten; S U Kass
Journal:  FEBS Lett       Date:  2000-07-28       Impact factor: 4.124

5.  Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.

Authors:  Ivan V Gregoretti; Yun-Mi Lee; Holly V Goodson
Journal:  J Mol Biol       Date:  2004-04-16       Impact factor: 5.469

Review 6.  Histone deacetylases.

Authors:  Paul A Marks; Thomas Miller; Victoria M Richon
Journal:  Curr Opin Pharmacol       Date:  2003-08       Impact factor: 5.547

7.  Structural basis for the assembly of the SMRT/NCoR core transcriptional repression machinery.

Authors:  Jasmeen Oberoi; Louise Fairall; Peter J Watson; Ji-Chun Yang; Zsolt Czimmerer; Thorsten Kampmann; Benjamin T Goult; Jacquie A Greenwood; John T Gooch; Bettina C Kallenberger; Laszlo Nagy; David Neuhaus; John W R Schwabe
Journal:  Nat Struct Mol Biol       Date:  2011-01-16       Impact factor: 15.369

8.  Improved side-chain torsion potentials for the Amber ff99SB protein force field.

Authors:  Kresten Lindorff-Larsen; Stefano Piana; Kim Palmo; Paul Maragakis; John L Klepeis; Ron O Dror; David E Shaw
Journal:  Proteins       Date:  2010-06

9.  Determination of alkali and halide monovalent ion parameters for use in explicitly solvated biomolecular simulations.

Authors:  In Suk Joung; Thomas E Cheatham
Journal:  J Phys Chem B       Date:  2008-07-02       Impact factor: 2.991

10.  CAVER 3.0: a tool for the analysis of transport pathways in dynamic protein structures.

Authors:  Eva Chovancova; Antonin Pavelka; Petr Benes; Ondrej Strnad; Jan Brezovsky; Barbora Kozlikova; Artur Gora; Vilem Sustr; Martin Klvana; Petr Medek; Lada Biedermannova; Jiri Sochor; Jiri Damborsky
Journal:  PLoS Comput Biol       Date:  2012-10-18       Impact factor: 4.475

View more
  4 in total

1.  Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis.

Authors:  Mark Miller; Arindom Pal; Wabel Albusairi; Hyun Joo; Beverly Pappas; Md Tariqul Haque Tuhin; Dengpan Liang; Raghavendra Jampala; Fang Liu; Jared Khan; Marjon Faaij; Miki Park; William Chan; Isabella Graef; Robert Zamboni; Neil Kumar; Jonathan Fox; Uma Sinha; Mamoun Alhamadsheh
Journal:  J Med Chem       Date:  2018-08-22       Impact factor: 7.446

Review 2.  Structural analyses of inositol phosphate second messengers bound to signaling effector proteins.

Authors:  Raymond D Blind
Journal:  Adv Biol Regul       Date:  2019-10-11

3.  Effects of a histone deacetylase 3 inhibitor on extinction and reinstatement of cocaine self-administration in rats.

Authors:  Leah N Hitchcock; Jonathan D Raybuck; Marcelo A Wood; K Matthew Lattal
Journal:  Psychopharmacology (Berl)       Date:  2018-11-28       Impact factor: 4.530

4.  Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDAC.

Authors:  Deborah Y Kwon; Ying-Tao Zhao; Janine M Lamonica; Zhaolan Zhou
Journal:  Nat Commun       Date:  2017-05-12       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.